This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA weighs higher standards for birth control pills
Washington reports the FDA, facing expert panel input, weighs stricter effectiveness standards for new contraceptives amid concerns newer pills may have higher failure rates due to lower hormone doses. The agency notes trials complicate direct comparisons and seeks broader trial inclusion. The meeting also covers marketing trials and upcoming products like Wyeth’s Lybrel.
MENTIONED IN THIS ARTICLE
Washington
Food and Drug Administration
U.S
Guttmacher Institute
U.K
Phibo
FDA
Karen Riley
Heather Boonstra
Wyeth Pharmaceuticals
Lybrel
Europe
Wyeth
Johnson & Johnson
Barr Pharmaceutical Inc
Barr